Tests for:
Genes that impact metabolism, insulin sensitivity, satiety and feeding behaviour.
Analytes measured:
Absorption and Metabolism
FABP2: Influences fat absorption and metabolism.
PPARG: Involved in adipocyte differentiation. It is a transcription factor activated by fatty acids, and is also involved in the regulation of glucose and lipid metabolism.
ADRB2: Involved in the mobilisation of fat from fat cells for energy, in response to catecholamines.
APOA5: Plays an important role in regulation of plasma triglycerides.
Fat Metabolism, Obesity and Satiety
APOA2: An abundant apolipoprotein in HDL. Plays a complex role in lipoprotein metabolism, insulin resistance, obesity and atherosclerosis susceptibility.
Regulation of Metabolism and Feeding Behaviour
MC4R: A strong obesity candidate gene, significantly associated with energy intake and expenditure.
Insulin Sensitivity and Regulation of Energy Intake
FTO: Involved in the regulation of arousal, appetite, temperature, autonomic function and endocrine system.
TCF7L2: Regulates blood glucose homeostasis, influencing both insulin secretion and sensitivity.
Exercise Responsiveness
ADBR3: Involved in the regulation of lypolysis that influences metabolism.
Circadian Rhythms
CLOCK: An essential regulatory arm of the biological clock, involved in metabolic regulation.
Fat Storage
PLIN: Influences diet-induced obesity.
Inflammation
TNF-A: TNFa is a pro-inflammatory cytokine, secreted by both macrophages and adipocytes, which has been shown to alter whole body glucose homeostasis, and has been implicated in the development of obesity, obesity-related insulin resistance and dyslipidemia.
Carbohydrate Sensitivity and Eating Behaviour
TAS1R2: Believed to contribute to the inter-individual variation in sugar consumption.
SLC2A2 (GLUT2): Influences the first step in glucose induced insulin secretion, affecting both food intake and regulation.
DRD2: Midbrain dopamine circuits may play an important role in both addiction and normal eating behaviour as they are involved in reward processing, particularly dopaminergic signalling via dopamine receptor 2 (DRD2).